Skip to main content
(352) 733-0111

Clinical trials

  • LEADER-PAD

    The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral…

    Investigator
    Samir K Shah
    Ages
    18 Years - N/A
    Sexes
    All
  • REGAIN

    A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.

    Investigator
    Ellen Satteson
    Ages
    18 Years - 65 Years
    Sexes
    All
  • PERMET

    The PERMET trial will determine whether metformin daily for six months improves six-minute walk performance in individuals with peripheral artery disease compared to placebo.

    Investigator
    Scott A Berceli
    Ages
    18 Years - N/A
    Sexes
    All